|1.||Moore, Ernest E: 4 articles (09/2008 - 06/2002)|
|2.||Freilich, Daniel: 3 articles (02/2012 - 03/2002)|
|3.||Wang, Xiang: 3 articles (09/2011 - 06/2009)|
|4.||Johnson, Jeffrey L: 3 articles (07/2006 - 06/2002)|
|5.||Bülow, Leif: 2 articles (04/2015 - 09/2012)|
|6.||Chen, Gang: 2 articles (01/2014 - 03/2007)|
|7.||Intaglietta, Marcos: 2 articles (07/2013 - 06/2011)|
|8.||Cabrales, Pedro: 2 articles (07/2013 - 06/2013)|
|9.||Dzemeshkevich, S L: 2 articles (01/2013 - 01/2012)|
|10.||Gladwin, Mark T: 2 articles (04/2012 - 12/2002)|
02/01/1963 - "[On causes and treatment of anemia developing after operations on the open heart under artificial blood circulation]."
09/01/2002 - "All the red cell substitutes in phase II trials have a life measured in hours and are unlikely to replace transfusions or drugs that stimulate erythropoiesis for chronic anemia, but they may play a role in cancer surgery, or even in radiation therapy, or in the management of cancer-related vascular occlusive syndromes."
11/01/1990 - "We evaluated the safety and efficacy of Fluosol DA-20% (FDA) as a blood substitute in the treatment of severe anemia. "
06/26/1986 - "We assessed the safety and efficacy of Fluosol-DA as a red-cell substitute in acute anemia. "
07/01/2002 - "Effects of a polymerized ultrapurified bovine hemoglobin blood substitute administered to ponies with normovolemic anemia."
06/01/1992 - "[The therapeutic efficacy of the blood substitute polyoxydin in experimental hemorrhagic shock]."
11/01/1996 - "Study of therapeutic efficiency of new blood substitutes in experimental hemorrhagic shock."
07/01/1993 - "In conclusion, the study demonstrates a remarkably salutary effect of LEH reconstituted with HTS as a blood substitute in the treatment of hemorrhagic shock."
01/01/1992 - "Study of effect of the newly developed artificial blood "Neo Red Cells (NRC)" on hemodynamics and blood gas transport in canine hemorrhagic shock."
11/01/1991 - "After further study and improvement NRC could be considered suitable as artificial blood for treatment of hemorrhagic shock."
10/01/2005 - "Profiling biochemical and hemodynamic markers using chronically instrumented, conscious and unrestrained rats undergoing severe, acute controlled hemorrhagic hypovolemic shock as an integrated in-vivo model system to assess new blood substitutes."
09/01/2004 - "Is there a role for blood substitutes in civilian medicine: a drug for emergency shock cases?"
12/01/1986 - "[Approaches to the development of complex blood substitutes for the treatment of shock]."
01/01/1984 - "Their wide clinical application as blood substitutes, anti-shock, and anti-ischemic agents seems imminent. "
01/01/1980 - "[Principle of creating complex blood substitutes for the treatment of the terminal phase of shock]."
|4.||Wounds and Injuries (Trauma)
03/01/1994 - "A comparative investigation of ultrastructural changes in the lungs of 28 cardiosurgical patients operated upon under conditions of bubble and membrane oxygenation of blood has established that the following trends are perspective for lessening the disturbances of the lung ultrastructure in operations on the open heart: shorter time of the first parallel blood flow when using bubble oxygenation, less trauma of the heart during artificial blood circulation due to the improved perfusion system, realization of the conditions of extrapulmonary oxygenation of blood, responsible for the prevention of hypoxic injuries of the lungs."
02/01/2012 - "Additional pre-clinical studies are indicated to identify optimal components of a multifunctional blood substitute for clinical use in trauma."
09/01/2005 - "Insights from studies of blood substitutes in trauma."
04/12/2004 - "Trauma-care revolution among benefits touted as blood substitute enters critical phase of clinical trials."
07/01/2006 - "The greatest need for blood substitutes worldwide is in patients with unanticipated acute blood loss, and trauma is the most likely scenario. "
01/01/2014 - "It is an effective and safe method to treat the celiomesenteric trunk aneurysm by using by-pass operation with artificial blood vessels, originating from inferior kidney aorta to visceral arteries including hepatic artery, splenic artery and superior mesenteric artery. "
03/20/2007 - "It is an effective and safe method to treat the aneurysm common trunk of malformed superior mesenteric artery and celiac trunk by using the artificial blood vessel by-pass from aorta to visceral arteries (hepatic, splenic, and superior mesenteric arteries) after controlling the initial part of common trunk and cutting off the aneurysm there."
06/01/1969 - "[Successful experience in resection of aortic arch aneurysm ad replacement with an artificial blood vessel]."
01/01/2015 - "We describe a case of DFA aneurysm in a patient who was successfully treated with aneurysmectomy and revascularization with an artificial blood vessel graft. "
12/01/2005 - "Under partial extracorporeal circulation, the aneurysm was excised, and replaced by an artificial blood vessel. "
|7.||glucuronyl glucosamine glycan sulfate (Vessel)
|8.||Nitric Oxide (Nitrogen Monoxide)
|2.||Blood Transfusion (Blood Transfusions)
|3.||Medication Errors (Medication Error)